New Zealand-based AI healthcare firm Toku Eyes has brought its retina-based AI health screening platform to the United States.
Its latest offering, the ORAiCLE, can assess and calculate a person's cardiovascular risk through a retinal scan. Still pending a patent, the AI technology uses an image of the back of a user's eye taken from a retinal camera. The platform spots minute changes in blood...
